BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Jin HL, Zhu H, Ling TS, Zhang HJ, Shi RH. Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: A meta-analysis. World J Gastroenterol 2009; 15(47): 5983-5991 [PMID: 20014464 DOI: 10.3748/wjg.15.5983]
URL: https://www.wjgnet.com/1007-9327/full/v15/i47/5983.htm
Number Citing Articles
1
Kosuke Narumiya, Ralf Metzger, Elfriede Bollschweiler, Hakan Alakus, Jan Brabender, Uta Drebber, Arnulf H Hölscher, Ute Warnecke-Eberz. Impact of ABCB1 C3435T polymorphism on lymph node regression in multimodality treatment of locally advanced esophageal cancerPharmacogenomics 2011; 12(2): 205 doi: 10.2217/pgs.10.174
2
M Kranzfelder, T Schuster, H Geinitz, H Friess, P Büchler. Meta-analysis of neoadjuvant treatment modalities and definitive non-surgical therapy for oesophageal squamous cell cancerBritish Journal of Surgery 2011; 98(6): 768 doi: 10.1002/bjs.7455
3
Daniel Vallböhmer, Jan Brabender, Peter Grimminger, Wolfgang Schröder, Arnulf H Hölscher. Predicting response to neoadjuvant therapy in esophageal cancerExpert Review of Anticancer Therapy 2011; 11(9): 1449 doi: 10.1586/era.11.126
4
Daniel Lin, Lawrence Leichman. The Current Status of Neoadjuvant Therapy for Esophageal CancerSeminars in Thoracic and Cardiovascular Surgery 2014; 26(2): 102 doi: 10.1053/j.semtcvs.2014.07.002
5
K. Maruyama, S. Motoyama, A. Anbai, S. Usami, Y. Sato, K. Shibuya, K. Yoshino, T. Nakatsu, Y. Minamiya, J.-I. Ogawa. Therapeutic strategy for the treatment of postoperative recurrence of esophageal squamous cell carcinoma: clinical efficacy of radiotherapyDiseases of the Esophagus 2011; 24(3): 166 doi: 10.1111/j.1442-2050.2010.01119.x
6
William S. Twaddell, Peter C. Wu, Roy J.J. Verhage, Marcus Feith, David H. Ilson, Christoph P. Schuhmacher, James D. Luketich, Björn Brücher, Daniel Vallböhmer, Wayne L. Hofstetter, Mark Jonathan Krasna, Daniela Kandioler, Paul M. Schneider, Bas P.L. Wijnhoven, Stephen J. Sontag. Barrett's esophagus: treatments of adenocarcinomas IIAnnals of the New York Academy of Sciences 2011; 1232(1): 265 doi: 10.1111/j.1749-6632.2011.06056.x
7
Luis F. Tapias, Christopher R. Morse. Minimally Invasive Ivor Lewis Esophagectomy after Induction Therapy Yields Similar Early Outcomes to Surgery AloneInnovations: Technology and Techniques in Cardiothoracic and Vascular Surgery 2011; 6(5): 331 doi: 10.1097/imi.0b013e3182364e5d
8
Kazuki Ishikawa, Kiyoshi Nakamatsu, Osamu Shiraishi, Takushi Yasuda, Yasumasa Nishimura. Clinical results of definitive-dose (50 Gy/25 fractions) preoperative chemoradiotherapy for unresectable esophageal cancerInternational Journal of Clinical Oncology 2015; 20(3): 531 doi: 10.1007/s10147-014-0736-9
9
Bryan H. Burmeister, Janine M. Thomas, Elizabeth A. Burmeister, Euan T. Walpole, Jennifer A. Harvey, Damien B. Thomson, Andrew P. Barbour, David C. Gotley, B. Mark Smithers. Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trialEuropean Journal of Cancer 2011; 47(3): 354 doi: 10.1016/j.ejca.2010.09.009
10
Marjolein Y.V. Homs, Martijn G.H. van Oijen, Bas P.L. Wijnhoven, Richard van Hillegersberg, Maureen de Boer-Dennert, Peter D. Siersema. Changes in diagnostic and treatment strategies of oesophageal cancer in the period from 2001 to 2009European Journal of Gastroenterology & Hepatology 2012; 24(2): 126 doi: 10.1097/MEG.0b013e32834e7f29
11
Meike M.C. Hirdes, Peter Siersema. Endoprosthetics for malignant esophageal diseaseTechniques in Gastrointestinal Endoscopy 2014; 16(2): 64 doi: 10.1016/j.tgie.2014.07.004
12
Mark D. Iannettoni. Invited CommentaryThe Annals of Thoracic Surgery 2011; 92(6): 2040 doi: 10.1016/j.athoracsur.2011.09.041
13
Geertjan van Tienhoven, Dirk J. Gouma, Dick J. Richel. Neoadjuvant chemoradiotherapy has a potential role in pancreatic carcinomaTherapeutic Advances in Medical Oncology 2011; 3(1): 27 doi: 10.1177/1758834010383150
14
K Kumagai, I Rouvelas, J A Tsai, D Mariosa, F Klevebro, M Lindblad, W Ye, L Lundell, M Nilsson. Meta-analysis of postoperative morbidity and perioperative mortality in patients receiving neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal and gastro-oesophageal junctional cancersBritish Journal of Surgery 2014; 101(4): 321 doi: 10.1002/bjs.9418
15
J. Straatman, P. J. M. Joosten, C. B. Terwee, M. A. Cuesta, E. P. Jansma, D. L. van der Peet. Systematic review of patient-reported outcome measures in the surgical treatment of patients with esophageal cancerDiseases of the Esophagus 2016; 29(7): 760 doi: 10.1111/dote.12405
16
Amin Doosti-Irani, Mohammad Ali Mansournia, Abbas Rahimi-Foroushani, Peiman Haddad, Kourosh Holakouie-Naieni. Local recurrence of esophageal squamous cell carcinoma after treatment: Comparison of frequentist and Bayesian network meta-analysisClinical Epidemiology and Global Health 2019; 7(2): 145 doi: 10.1016/j.cegh.2018.02.009
17
Li-Li Zhu, Ling Yuan, Hui Wang, Lin Ye, Gui-Ying Yao, Cui Liu, Niu-Niu Sun, Xiao-Jing Li, Shi-Cong Zhai, Ling-Juan Niu, Jun-Bo Zhang, Hong-Long Ji, Xiu-Min Li, Kevin Camphausen. A Meta-Analysis of Concurrent Chemoradiotherapy for Advanced Esophageal CancerPLOS ONE 2015; 10(6): e0128616 doi: 10.1371/journal.pone.0128616
18
A. van Nunen, M.J.C. van der Sangen, M. van Boxtel, P.M.A. van Haaren. Cone-Beam CT-based position verification for oesophageal cancer: Evaluation of registration methods and anatomical changes during radiotherapyTechnical Innovations & Patient Support in Radiation Oncology 2017; : 30 doi: 10.1016/j.tipsro.2017.07.002
19
Bin Zheng, Wei Zheng, Yong Zhu, Xiao-yan Lin, Ben-hua Xu, Chun Chen. Role of adjuvant chemoradiotherapy in treatment of resectable esophageal carcinoma: a meta-analysisChinese Medical Journal 2013; 126(6): 1178 doi: 10.3760/cma.j.issn.0366-6999.20121798
20
Laurent Bedenne, Julie Vincent, Jean-Louis Jouve. Is surgery always necessary in esophageal cancer?Esophagus 2011; 8(1): 3 doi: 10.1007/s10388-011-0258-8
21
Amy M. Buckley, Margaret R. Dunne, Niamh Lynam-Lennon, Susan A. Kennedy, Aoife Cannon, Alison L. Reynolds, Stephen G. Maher, John V. Reynolds, Breandán N. Kennedy, Jacintha O'Sullivan. Pyrazinib (P3), [(E)-2-(2-Pyrazin-2-yl-vinyl)-phenol], a small molecule pyrazine compound enhances radiosensitivity in oesophageal adenocarcinomaCancer Letters 2019; 447: 115 doi: 10.1016/j.canlet.2019.01.009
22
A. H. Hölscher, E. Bollschweiler. Early Gastrointestinal CancersRecent Results in Cancer Research 2012; 196: 169 doi: 10.1007/978-3-642-31629-6_11
23
K. Ott, L. Sisic, M. Büchler. Plattenepithelkarzinom des ÖsophagusDer Chirurg 2011; 82(11): 974 doi: 10.1007/s00104-011-2128-2
24
Masanobu Nakajima, Hiroyuki Kato. Treatment options for esophageal squamous cell carcinomaExpert Opinion on Pharmacotherapy 2013; 14(10): 1345 doi: 10.1517/14656566.2013.801454
25
Yu-Zhen Zheng, Wei Zhao, Yi Hu, Xiao-Xiao Ding-Lin, Jing Wen, Hong Yang, Qian-Wen Liu, Kong-Jia Luo, Qing-Yuan Huang, Jun-Ying Chen, Jian-Hua Fu. Aggressive surgical resection does not improve survival in operable esophageal squamous cell carcinoma with N2-3 statusWorld Journal of Gastroenterology 2015; 21(28): 8644-8652 doi: 10.3748/wjg.v21.i28.8644
26
Haiming Feng, Ye Zhao, Tao Jing, Jianxing Ma, Yinglu Zhao, Jianhua Zhang, Cheng Wang, Bin Li. Traditional and cumulative meta‑analysis: Chemoradiotherapy followed by surgery versus surgery alone for resectable esophageal carcinomaMolecular and Clinical Oncology 2017;  doi: 10.3892/mco.2017.1534
27
Yasunori Akutsu, Shigeo Yasuda, Matsuo Nagata, Yosuke Izumi, Shinichi Okazumi, Hideaki Shimada, Yukio Nakatani, Hirohiko Tsujii, Tadashi Kamada, Shigeru Yamada, Hisahiro Matsubara. A phase I/II clinical trial of preoperative short‐course carbon‐ion radiotherapy for patients with squamous cell carcinoma of the esophagusJournal of Surgical Oncology 2012; 105(8): 750 doi: 10.1002/jso.22127
28
Amy M. Buckley, Niamh Lynam-Lennon, Susan A. Kennedy, Margaret R. Dunne, John J. Aird, Emma K. Foley, Niamh Clarke, Narayanasamy Ravi, Dermot O’Toole, John V. Reynolds, Breandán N. Kennedy, Jacintha O’Sullivan. Leukaemia inhibitory factor is associated with treatment resistance in oesophageal adenocarcinomaOncotarget 2018; 9(72): 33634 doi: 10.18632/oncotarget.25950
29
Cheng-Che Tu, Po-Kuei Hsu. Current choices and prospects in management of postoperative esophageal cancer patientsAsian Journal of Surgery 2019; 42(1): 81 doi: 10.1016/j.asjsur.2018.06.009
30
Sebastien Gilbert, Gillian K. Gresham, Derek J. Jonker, Andrew J. Seely, Donna E. Maziak, Farid M. Shamji, Jason Pantarotto, Sudhir Sundaresan. Impact of Patient Selection, Disease Progression, and Adverse Events on Esophageal Cancer Outcomes After Trimodality TherapyThe Annals of Thoracic Surgery 2012; 94(5): 1659 doi: 10.1016/j.athoracsur.2012.05.044
31
Dong-Bin Wang, Zhong-Yi Sun, Li-Min Deng, De-Qing Zhu, Hong-Gang Xia, Peng-Zhi Zhu. Neoadjuvant Chemoradiotherapy Improving Survival Outcomes for Esophageal CarcinomaChinese Medical Journal 2016; 129(24): 2974 doi: 10.4103/0366-6999.195464
32
Cengiz Gemici, Gokhan Yaprak, Hasan Fevzi Batirel, Mahmut Ilhan, Alpaslan Mayadagli. Radiation field size and dose determine oncologic outcome in esophageal cancerWorld Journal of Surgical Oncology 2016; 14(1) doi: 10.1186/s12957-016-1024-0
33
Alex G. Little, Antoon E. Lerut, David H. Harpole, Wayne L. Hofstetter, John D. Mitchell, Nasser K. Altorki, Mark J. Krasna. The Society of Thoracic Surgeons Practice Guidelines on the Role of Multimodality Treatment for Cancer of the Esophagus and Gastroesophageal JunctionThe Annals of Thoracic Surgery 2014; 98(5): 1880 doi: 10.1016/j.athoracsur.2014.07.069
34
Yunpeng Zhao, Yongqiang Wang, Lei Shan, Chuanliang Peng, Wenhao Zhang, Xiaogang Zhao. A network meta-analysis for neoadjuvant and adjuvant treatments for resectable squamous cell carcinoma of esophagusScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-86102-8
35
Keiichi Jingu, Hisanori Ariga, Kenji Nemoto, Kakutaro Narazaki, Rei Umezawa, Ken Takeda, Masashi Koto, Toshiyuki Sugawara, Masaki Kubozono, Go Miyata, Ko Onodera, Shogo Yamada. Long-Term Results of Radiochemotherapy for Solitary Lymph Node Metastasis After Curative Resection of Esophageal CancerInternational Journal of Radiation Oncology*Biology*Physics 2012; 83(1): 172 doi: 10.1016/j.ijrobp.2011.06.1978
36
Fang Li, Tao Li, Li Liu, Jiahua Lv, Yanqiong Song, Churong Li, Peng Diao. Concurrent versus Sequential Chemoradiotherapy for Esophageal Cancer among Chinese Population: A Meta-AnalysisTumori Journal 2015; 101(4): 353 doi: 10.5301/tj.5000314
37
Karsten Bartels, Matthew Fiegel, Quinn Stevens, Bryan Ahlgren, Nathaen Weitzel. Approaches to Perioperative Care for EsophagectomyJournal of Cardiothoracic and Vascular Anesthesia 2015; 29(2): 472 doi: 10.1053/j.jvca.2014.10.029
38
Luis F. Tapias, Douglas J. Mathisen, Cameron D. Wright, John C. Wain, Henning A. Gaissert, Ashok Muniappan, Michael Lanuti, Dean M. Donahue, Christopher R. Morse. Outcomes With Open and Minimally Invasive Ivor Lewis Esophagectomy After Neoadjuvant TherapyThe Annals of Thoracic Surgery 2016; 101(3): 1097 doi: 10.1016/j.athoracsur.2015.09.062
39
Marcus W. Wiedmann, Joachim Mössner. International Manual of Oncology Practice2015; : 201 doi: 10.1007/978-3-319-21683-6_10
40
Ravi Shridhar, Khaldoun Almhanna, Sarah E. Hoffe, Matthew Biagioli, Domenico Coppola, Kenneth L. Meredith. The American Cancer Society's Oncology in Practice2018; : 33 doi: 10.1002/9781118592168.ch3
41
Ravi Shridhar, Reza Imani-Shikhabadi, Bonnie Davis, Oscar A. Streeter, Charles R. Thomas. Curative Treatment of Esophageal Cancer; An Evidenced Based ReviewJournal of Gastrointestinal Cancer 2013; 44(4): 375 doi: 10.1007/s12029-013-9511-9
42
Kelvin K. W. Chan, Ronak Saluja, Keemo Delos Santos, Kelly Lien, Keya Shah, Gemma Cramarossa, Xiaofu Zhu, Rebecca K.S. Wong. Neoadjuvant treatments for locally advanced, resectable esophageal cancer: A network meta‐analysisInternational Journal of Cancer 2018; 143(2): 430 doi: 10.1002/ijc.31312
43
Ravi Shridhar, Khaldoun Almhanna, Kenneth L. Meredith, Matthew C. Biagioli, Michael D. Chuong, Alex Cruz, Sarah E. Hoffe. Radiation Therapy and Esophageal CancerCancer Control 2013; 20(2): 97 doi: 10.1177/107327481302000203
44
Reema Goel, Rathan M. Subramaniam, Jason W. Wachsmann. PET/Computed Tomography Scanning and Precision MedicinePET Clinics 2017; 12(4): 373 doi: 10.1016/j.cpet.2017.05.001
45
Christine Kestens, Richard van Hillegersberg, Peter Siersema. Ontwikkelingen in de oncologie2014; : 231 doi: 10.1007/978-90-368-0436-3_24
46
Deirdre J Cohen, Jaffer Ajani. An expert opinion on esophageal cancer therapyExpert Opinion on Pharmacotherapy 2011; 12(2): 225 doi: 10.1517/14656566.2010.517748
47
Mark Stavas, A. Bapsi Chakravarthy. Esophageal Cancer2015; : 157 doi: 10.1007/978-3-319-20068-2_10
48
Basil S. Nasir, Moishe Liberman. Difficult Decisions in Thoracic SurgeryDifficult Decisions in Surgery: An Evidence-Based Approach 2014; 1: 287 doi: 10.1007/978-1-4471-6404-3_23
49
Peter S. N. van Rossum, Richard van Hillegersberg, Frederiek M. Lever, Irene M. Lips, Astrid L. H. M. W. van Lier, Gert J. Meijer, Maarten S. van Leeuwen, Marco van Vulpen, Jelle P. Ruurda. Imaging strategies in the management of oesophageal cancer: what’s the role of MRI?European Radiology 2013; 23(7): 1753 doi: 10.1007/s00330-013-2773-6
50
Pierfrancesco Franco, Alba Fiorentino, Francesco Dionisi, Michele Fiore, Silvia Chiesa, Stefano Vagge, Francesco Cellini, Luciana Caravatta, Mario Tombolini, Fiorenza De Rose, Icro Meattini, Gianluca Mortellaro, Giuseppina Apicella, Lorenza Marino, Daniela Greto. Combined Modality Therapy for Thoracic and head and Neck Cancers: A Review of Updated Literature Based on a Consensus MeetingTumori Journal 2016; 102(5): 459 doi: 10.5301/tj.5000525
51
Kaushik Mukherjee, A. Bapsi Chakravarthy, Laura W. Goff, Wael El-Rifai. Esophageal Adenocarcinoma: Treatment Modalities in the Era of Targeted TherapyDigestive Diseases and Sciences 2010; 55(12): 3304 doi: 10.1007/s10620-010-1187-4
52
Xavier Cuenca, Christophe Hennequin, Elif Hindié, Sofia Rivera, Laetitia Vercellino, Valérie Baruch-Hennequin, Jean-Marc Gornet, Pierre Cattan, Mircea Chirica, Laurent Quéro. Evaluation of early response to concomitant chemoradiotherapy by interim 18F-FDG PET/CT imaging in patients with locally advanced oesophageal carcinomasEuropean Journal of Nuclear Medicine and Molecular Imaging 2013; 40(4): 477 doi: 10.1007/s00259-012-2325-3
53
Han-Ting Zhu, Da-Shan Ai, Hua-Rong Tang, Harun Badakhshi, Jian-Hong Fan, Jia-Ying Deng, Jun-Hua Zhang, Yun Chen, Zhen Zhang, Yi Xia, Xiao-Mao Guo, Guo-Liang Jiang, Kuai-Le Zhao. Long-term results of paclitaxel plus cisplatin with concurrent radiotherapy for loco-regional esophageal squamous cell carcinomaWorld Journal of Gastroenterology 2017; 23(3): 540-546 doi: 10.3748/wjg.v23.i3.540
54
Amy Buckley, Becky Bibby, Margaret Dunne, Susan Kennedy, Maria Davern, Breandán Kennedy, Stephen Maher, Jacintha O’Sullivan. Characterisation of an Isogenic Model of Cisplatin Resistance in Oesophageal Adenocarcinoma CellsPharmaceuticals 2019; 12(1): 33 doi: 10.3390/ph12010033
55
Neil Bryan Newman, A. Bapsi Chakravarthy. Esophageal Cancer2020; : 199 doi: 10.1007/978-3-030-29832-6_10
56
Felice Pasini, Anna Paola Fraccon, Giovanni de Manzoni. Treatment of Esophageal and Hypopharyngeal Squamous Cell CarcinomaUpdates in Surgery 2012; : 131 doi: 10.1007/978-88-470-2330-7_12
57
M. Hingorani, T. Crosby, A. Maraveyas, S. Dixit, A. Bateman, R. Roy. Neoadjuvant Chemoradiotherapy for Resectable Oesophageal and Gastro-oesophageal Junction Cancer—Do We Need Another Randomised Trial?Clinical Oncology 2011; 23(10): 696 doi: 10.1016/j.clon.2011.05.005
58
R. J. L. F. Loffeld, P. E. P. Dekkers. Experience with Oesophageal Cancer: A Ten-Year Single Centre Study Reflecting Daily PracticeISRN Gastroenterology 2013; 2013: 1 doi: 10.1155/2013/205417
59
Lindsay Danielle Kumble, Elisabeth Silver, Aaron Oh, Julian A Abrams, Joshua R Sonett, Chin Hur. Treatment of early stage (T1) esophageal adenocarcinoma: Personalizing the best therapy choiceWorld Journal of Meta-Analysis 2019; 7(9): 406-417 doi: 10.13105/wjma.v7.i9.406
60
Christine Kestens, Richard van Hillegersberg, Peter Siersema. OesofaguscarcinoomHuisarts en wetenschap 2014; 57(1): 34 doi: 10.1007/s12445-014-0015-z
61
Luis F. Tapias, Christopher R. Morse. Minimally Invasive Ivor Lewis Esophagectomy after Induction Therapy Yields Similar Early Outcomes to Surgery AloneInnovations: Technology and Techniques in Cardiothoracic and Vascular Surgery 2011; 6(5): 331 doi: 10.1177/155698451100600508
62
O. Dupuis, G. Ganem, G. Béra, Y. Pointreau, O. Pradier, P. Martin, X. Mirabel, F. Denis. Cancer de l’œsophageCancer/Radiothérapie 2010; 14: S74 doi: 10.1016/S1278-3218(10)70010-X
63
Ryan P. Merkow, Karl Y. Bilimoria, Martin D. McCarter, Warren B. Chow, Clifford Y. Ko, David J. Bentrem. Use of Multimodality Neoadjuvant Therapy for Esophageal Cancer in the United States: Assessment of 987 HospitalsAnnals of Surgical Oncology 2012; 19(2): 357 doi: 10.1245/s10434-011-1945-3
64
Peng Jin, Astrid van der Horst, Rianne de Jong, Jeanin E. van Hooft, Martijn Kamphuis, Niek van Wieringen, Melanie Machiels, Arjan Bel, Maarten C.C.M. Hulshof, Tanja Alderliesten. Marker-based quantification of interfractional tumor position variation and the use of markers for setup verification in radiation therapy for esophageal cancerRadiotherapy and Oncology 2015; 117(3): 412 doi: 10.1016/j.radonc.2015.10.005
65
Jiaying Deng, Chunyu Wang, Mingqiong Xiang, Fatao Liu, Yun Liu, Kuaile Zhao. Meta-analysis of postoperative efficacy in patients receiving chemoradiotherapy followed by surgery for resectable esophageal carcinomaDiagnostic Pathology 2014; 9(1) doi: 10.1186/1746-1596-9-151
66
Arnulf H. Hölscher, Ulrich K. Fetzner. Multimodale Therapie mit kurativem AnsatzViszeralmedizin 2012; 28(2): 113 doi: 10.1159/000338283
67
Lei Jiang, Ke-hu Yang, Quan-lin Guan, Yan Chen, Peng Zhao, Jin-hui Tian. Survival Benefit of Neoadjuvant Chemotherapy for Resectable Cancer of the Gastric and Gastroesophageal JunctionJournal of Clinical Gastroenterology 2015; 49(5): 387 doi: 10.1097/MCG.0000000000000212
68
Dong-Bin Wang, Xun Zhang, Hong-Li Han, Yi-Jun Xu, Da-Qiang Sun, Zhen-Liang Shi. Neoadjuvant Chemoradiotherapy Could Improve Survival Outcomes for Esophageal Carcinoma: A Meta-AnalysisDigestive Diseases and Sciences 2012; 57(12): 3226 doi: 10.1007/s10620-012-2263-8
69
Aminah Jatoi, Gamini Soori, Nathan R. Foster, Bradley K. Hiatt, James A. Knost, Tom R. Fitch, Matthew D. Callister, Francis C. Nichols, Tim M. Husted, Steven R. Alberts. Phase II Study of Preoperative Pemetrexed, Carboplatin, and Radiation Followed by Surgery for Locally Advanced Esophageal Cancer and Gastroesophageal Junction TumorsJournal of Thoracic Oncology 2010; 5(12): 1994 doi: 10.1097/JTO.0b013e3181fb5c3e
70
Yaping Xu, Xinmin Yu, Qixun Chen, Weimin Mao. Neoadjuvant versus adjuvant treatment: which one is better for resectable esophageal squamous cell carcinoma?World Journal of Surgical Oncology 2012; 10(1) doi: 10.1186/1477-7819-10-173
71
H X Yang, W Feng, J C Wei, T S Zeng, Z D Li, L J Zhang, P Lin, R Z Luo, J H He, J H Fu. Support vector machine-based nomogram predicts postoperative distant metastasis for patients with oesophageal squamous cell carcinomaBritish Journal of Cancer 2013; 109(5): 1109 doi: 10.1038/bjc.2013.379
72
J. Stiekema, H. Boot, B.M.P. Aleman, L.F.A. Wessels, J.W. van Sandick. Prognostication and prediction using gene expression profiling in oesophageal cancerEuropean Journal of Surgical Oncology (EJSO) 2013; 39(1): 17 doi: 10.1016/j.ejso.2012.07.008
73
Leila Sisic, Susanne Blank, Wilko Weichert, Dirk Jäger, Christoph Springfeld, Marcel Hochreiter, Markus Büchler, Katja Ott. Prognostic impact of lymph node involvement and the extent of lymphadenectomy (LAD) in adenocarcinoma of the esophagogastric junction (AEG)Langenbeck's Archives of Surgery 2013; 398(7): 973 doi: 10.1007/s00423-013-1101-6
74
Nathan W. Bronson, Renato A. Luna, John G. Hunter. Tailoring Esophageal Cancer SurgerySeminars in Thoracic and Cardiovascular Surgery 2012; 24(4): 275 doi: 10.1053/j.semtcvs.2012.11.001
75
Thomas W. Rice. The Esophagus2012; : 637 doi: 10.1002/9781444346220.ch35
76
Magali Cabau, Guillaume Luc, Eric Terrebonne, Geneviève Belleanne, Véronique Vendrely, Antonio Sa Cunha, Denis Collet. Lymph node invasion might have more prognostic impact than R status in advanced esophageal adenocarcinomaThe American Journal of Surgery 2013; 205(6): 711 doi: 10.1016/j.amjsurg.2012.08.009
77
Peter D. Siersema, Frank P. Vleggaar. Esophageal strictures, tumors, and fistulae: alternative techniques for palliating primary esophageal cancerTechniques in Gastrointestinal Endoscopy 2010; 12(4): 203 doi: 10.1016/j.tgie.2011.02.015
78
Ranjit Joseph, Shachar Laks, Michael Meyers, Autumn J. McRee. Multidisciplinary Approach to the Management of Esophageal MalignanciesWorld Journal of Surgery 2017; 41(7): 1726 doi: 10.1007/s00268-017-4009-4